Süleyman Göksu (Suleyman Goksu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Structure Activity Relationship

Cognitive Decline

Top Venues

Archiv der Pharmazie

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Rafika El Ati, Necla Öztaşkın, Ahmet Çağan, Akın Akıncıoğlu, Malihe Moradzadeh, Süleyman Göksu, Rachid Touzani, İlhami Gülçin
Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions. Archiv der Pharmazie 357 (6) (2024)
Rafika El Ati, Necla Öztaşkın, Ahmet Çağan, Akın Akıncıoğlu, Malihe Moradzadeh, Süleyman Göksu, Rachid Touzani, İlhami Gülçin
Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions. Archiv der Pharmazie 357 (6) (2024)
Rafika El Ati, Necla Öztaşkın, Ahmet Çağan, Akın Akıncıoğlu, Malihe Moradzadeh, Süleyman Göksu, Rachid Touzani, İlhami Gülçin
Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions. Archiv der Pharmazie (2024)
Necla Oztaskin, Süleyman Göksu, Yeliz Demir, Ahmet Maras, İlhami Gulçin
Synthesis of Novel Bromophenol with Diaryl Methanes-Determination of Their Inhibition Effects on Carbonic Anhydrase and Acetylcholinesterase. Molecules (Basel, Switzerland) 27 (21) (2022)
Nihal Gök, Akın Akıncıoğlu, Edanur Erümit Binici, Hülya Akıncıoğlu, Namık Kılınç, Süleyman Göksu
Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities. Archiv der Pharmazie 354 (7) (2021)
Yeliz Demir, Parham Taslimi, Muhammet Serhat Ozaslan, Necla Oztaskin, Yasin Çetinkaya, İlhami Gulçin, Şükrü Beydemir, Süleyman Göksu
Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes. Archiv der Pharmazie 351 (12) (2018)
Kadir Aksu, Hülya Akıncıoğlu, Akın Akıncıoğlu, Süleyman Göksu, Ferhan Tümer, İlhami Gülçin
Synthesis of novel sulfamides incorporating phenethylamines and determination of their inhibition profiles against some metabolic enzymes. Archiv der Pharmazie 351 (9) (2018)